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ABSTRACT 
 
 This dissertation is focused on the functional characterization of 
H4(D10S170), a gene frequently rearranged with RET in Papillary Thyroid 
Carcinomas, and in particular on its involvement in ATM-dependent response 
to DNA damage.  
 Exposure to ionizing radiation is a well-known risk factor for thyroid 
cancer carrying the RET/PTC oncogenes. In fact, radiation exposure results in 
extensive DNA damage, including double strand breaks and chromosomal 
rearrangements. In human papillary thyroid carcinomas the rearrangement of 
the RET protooncogene with a number of heterologous genes generates the 
RET/papillary thyroid carcinoma (PTC) oncogenes. One of the most frequent 
variants of these recombination events is the fusion of the intracellular kinase-
encoding domain of RET to the first 101 amino acids of a gene named 
H4(D10S170), where the spatial contiguity of RET and H4 chromosomal loci 
might be responsible for the high frequency of RET/PTC1 radiation-induced 
rearrangements in thyroid human cells. 
 The H4(D10S170) gene product is an ubiquitously expressed 55 KDa 
nuclear and cytosolic protein that is phosphorylated following serum 
stimulation. This phosphorylation depends on mitogen-activated protein kinase 
(MAPK) Erk1/2 activity and is associated to the relocation of H4(D10S170) 
from the nucleus to the cytosol. Overexpression of the H4(D10S170) gene was 
able to induce apoptosis of thyroid follicular epithelial cells; conversely a 
carboxy-terminal truncated mutant, H4(1-101), corresponding to the portion of 
H4(D10S170) included in the RET/PTC1 oncoprotein, behaved as dominant 
negative on the proapoptotic function and nuclear localization. More 
interestingly, the conditional expression of H4(1-101) and of H4(S244)A 
mutants protect cells from ionizing radiation, too. These latter findings may 
imply that the transforming potential of RET/PTC1 is not only confined to the 
RET tyrosine kinase activation, but also to the disruption of the H4 function. 
 The DNA damage signalling pathway is a highly conserved response to 
genotoxic stress. In mammalian cells the pathway functions to protect cells 
from agents that induce cellular death or transformation, where it participates 
in DNA repair and checkpoint control leading to survival or apoptosis. The 
ATM kinase, a central mediator of responses to DNA double-strand breaks, in 
cells phosphorylates a limited number of downstream protein targets in 
response to DNA damage. 
In this dissertation we investigated the potential role of H4(D10S170) in DNA 
damage signaling pathways.  
 Several consensus phosphorylation sites for ATM might be present in 
H4(D10S170) protein, as predicted  by profile scan primary sequence analysis, 
and also conserved in the various species in which H4(D10S170) is present, 
thus suggesting that H4(D10S170) might be a direct target of ATM.  
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We found that in cells treated with the DNA damaging agents, i.e. ionizing 
radiation or etoposide, H4(D10S170) underwent ATM-mediated 
phosphorylation at Thr 434, stabilizing nuclear H4.  
 In ataxia teleangectasia lymphoblast cell lines endogenous 
H4(D10S170) was  localized to cytoplasm and was excluded from the nucleus. 
Moreover, H4(D10S170) was not phosphorylated in ATM-deficient 
lymphoblasts after ionizing irradiation. Inhibition of ATM kinase interfered 
with H4(D10S170) apoptotic activity and expression of a dominant negative 
H4-mutant, H4T434A, protected the cells from genotoxic stress-induced 
apoptosis. Most importantly, silencing of H4(D10S170) in mammalian cells 
increased cell survival, DNA synthesis and cell doublings after exposure to 
ionizing radiation. 
 Our results suggest that H4(D10S170) is involved in cellular response 
to DNA damage ATM-mediated and that the loss of H4(D10S170) gene 
function might have a role in thyroid carcinogenesis by impairing apoptosis 
and by promoting DNA synthesis resistant to genotoxic stress. 
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1. INTRODUCTION 
 
1.1 Thyroid Cancer 
Carcinoma of the thyroid gland is the most common malignancy of the 
endocrine system. 
 The thyroid gland is composed by two distinct hormone-producing cell 
types: follicular cells and parafollicular C cells. Follicular cells comprise most 
of the epithelium and are responsible for iodine uptake and thyroid hormone 
synthesis. C cells are scattered intrafollicular or parafollicular cells and are 
dedicated to the production of the calcium-regulating hormone calcitonin. 
More than 95% of thyroid carcinomas are derived from follicular cells while a 
minority of tumours (3%), referred to as medullary thyroid carcinoma, are of 
C-cell origin. 
 Thyroid cancer affects women more often than men and usually occurs 
in people between the ages of 25 and 65 years. The incidence of this 
malignancy has been increasing over the last decade.  
Patients with a history of radiation administered in infancy and 
childhood for benign conditions of the head and neck, such as enlarged thymus, 
acne, or tonsillar or adenoidal enlargement, have an increased risk of cancer as 
well as other abnormalities of the thyroid gland. In this group of patients, 
malignancies of the thyroid gland first appear beginning as early as 5 years 
following radiation and may appear 20 or more years later. Other risk factors 
for the development of thyroid cancer include a history of goiter, family history 
of thyroid disease, female gender, and Asian race.  
 Thyroid carcinomas are broadly divided into well-differentiated, poorly 
differentiated and undifferentiated types on the basis of histological and 
clinical parameters (Table 1). Differentiated tumors (papillary or follicular) are 
highly treatable and usually curable. Poorly differentiated tumors (medullary 
and anaplastic) are much less common, are aggressive, metastasize early, and 
have a much poorer prognosis. The 10-year overall relative survival rates for 
patients in the United States are 93% for papillary cancer, 85% for follicular 
cancer, 75% for medullary cancer, and 14% for undifferentiated/anaplastic 
cancer.  
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Figure 1. Classification of thyroid carcinomas. For clinical management of the patient, 
thyroid cancer is generally divided into 2 categories: well differentiated or poorly 
differentiated. 
 
 Papillary thyroid carcinomas (PTCs) account for around 60 to 80% of 
all thyroid cancers and are closely linked to ionizing irradiation (Ron et al. 
1995). Young children are particularly susceptible since thyroid growth occurs 
primarily in childhood. A striking increase in PTC has been reported in 
Belarus, Ukraine and Western regions of Russia, following the Chernobyl 
disaster of 1986. The worldwide incidence of thyroid cancer in children has 
been estimated in the order of 1 per million children per year, while it 
increased by more than 30 fold after the Chernobyl disaster in the exposed 
areas (Williams 2002). PTC shows typically multicentricity and a tendency to 
spread into lymphatic vessels; regional node metastases at presentation are 
found in a significant proportion of cases. There are several PTC variants 
including solid-follicular, follicular, tall-cell, hurthle cell variants (Ostrowski et 
al. 1996). 
 About 10 to 30% of thyroid cancers are Follicular thyroid carcinoma 
(FTC). FTC is linked to dietary iodine deficiency (Williams et al. 1977) and 
shows variable morphology ranging from well-formed colloid-containing 
follicles, to solid or trabecular growth pattern. Therapy for both PTC and FTC 
consists in surgery followed by metabolic treatment with 131I. Prognosis is very 
good with a survival rate at 10 years ranging from 90 to 98%. 
 Anaplastic thyroid carcinoma (ATC) is the most aggressive type of 
thyroid cancer. ATC cells are extremely abnormal and spread rapidly to other 
 
 
11 
parts of the body. ATC make up only about 1% of all thyroid cancers and 
typically spreads beyond the thyroid by direct local extension. Metastases to 
regional nodes are also common but their presence is often masked by the 
presence of extensive soft tissue invasion. Distant metastases may be present in 
any site. No effective therapy is known for ATC and prognosis is very 
unfavourable with a mean survival time of less than one year. 
Medullary thyroid carcinoma (MTC) develops from neuroendocrine C 
cells of the thyroid, producing calcitonin (CT). About 5 to 7% of all thyroid 
cancers are MTC that can be sporadic or familial as part of the Multiple 
Endocrine Neoplasia type 2 syndromes. MEN2 syndromes are inherited cancer 
disorders divided in three types: MEN2A, characterized by MTC, 
pheochromocytoma and parathyroid adenoma; MEN2B characterized by MTC, 
pheochromocytoma and additional tumors such as neuromas and 
ganglioneuromas of the gut; Familial Medullary Thyroid Carcinoma or FMTC 
whose only feature is MTC. MEN2 is inherited as a highly penetrant mendelian 
tract and this genetic transmission is due to gain-of-function mutations of the 
RET gene. MTC tends to metastasize to lymph-nodes and distant organs, the 
treatment consists in surgical removal of the lesion. Thus, MTC are fairly 
resistant to most chemotherapeutic agents. 
  
1.2 Molecular Basis Of Well-Differentiated Thyroid Carcinoma 
 In well-differentiated thyroid carcinoma non-overlapping, activating 
events that involve the genes RET, NTRK1 (neurotrophic tyrosine kinase 
receptor 1), BRAF or Ras are detectable in nearly 70% of all cases. 
 The rearranged during tansfection (RET) proto-oncogene was isolated 
in 1985 and was the first activated receptor-tyrosine kinase to be identified in 
thyroid cancer (Takahashi et al 1988). The proto-oncogene, located on 
chromosome 10q11.2, encodes a transmembrane receptor-tyrosine kinase with 
four cadherin-related motifs in the extracellular domain. RET is normally 
expressed in the developing central and peripheral nervous systems and is an 
essential component of a signalling pathway that is required for renal 
organogenesis and enteric neurogenesis. Glial-derived neurotrophic factor 
(GDNF)-family ligands and GDNF-family receptor-alpha (GFRalpha) bind the 
extracellular domain of RET to induce tyrosine kinase autophosphorylation 
that activates several signalling pathways, including extracellular regulated 
kinase (ERK), phosphatidylinositol 3-kinase (PI3K), MAPK p38 and C-JUN 
kinase (JNK). 
Gain-of-function mutations of RET are involved in sporadic and familial C-
cell-derived medullary thyroid carcinoma, including multiple endocrine 
neoplasia 2A (MEN2A), MEN2B and familial medullary thyroid carcinoma. 
By contrast, chimeric oncogenes, designated RET/PTC, are implicated in the 
development of papillary carcinoma. Somatic chromosomal rearrangement 
leads to fusion of the 3'-terminal sequence of RET, which encodes the tyrosine 
kinase domain, with the 5'-terminal sequences of heterologous genes (Fig. 2).  
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Figure 2. Chromosome 10q inversion in papillary thyroid carcinoma.  Schematic view of 
the paracentric inversion of chromosome 10q generating the transforming sequence RET/PTC. 
There are at least 10 different types of RET/PTC, all resulting from the fusion of the tyrosine 
kinase domain of RET to the 5' portion of different genes. RET/PTC1 and RET/PTC3 are the 
most common types, accounting for >90% of all rearrangements. The arrows indicate the 
breackpoints. 
 
 Although wild-type RET is not normally expressed in follicular cells, 
RET/PTC chimeric oncoproteins, that lack a signal peptide and transmembrane 
domain, are expressed in the cytoplasm of follicular cells under the control of 
the newly acquired promoters. Ligand-independent tyrosine phosphorylation is 
induced by constitutive dimerization of the fusion proteins. 
The reported overall prevalence of RET/PTC rearrangements in papillary 
carcinomas varies from 13–43%. More than 10 RET/PTC rearrangements have 
been described in sporadic and radiation-associated papillary carcinoma, 
Among them the most common forms are H4(D10S170)–RET (also known as 
RET/PTC1) and ELE1–RET (also known as RET/PTC3).  
 Rearrangements involving the RET gene are common in radiation-
associated papillary thyroid cancer (PTC) and patients with a history of 
medical irradiation.  
 The RET/PTC1 type of rearrangement is an inversion of chromosome 
10 mediated by illegitimate recombination between the RET and the H4 genes, 
which are 30 megabases apart. Despite the great linear distance between them, 
RET and H4 recombination might be promoted by their proximity in the 
nucleus. Spatial contiguity of RET and H4 within interphase nuclei may 
provide a structural basis for generation of RET/PTC1 rearrangement by 
allowing a single radiation track to produce a double-strand break in each gene 
at the same site in the nucleus (Nikiforova 2000) (Fig. 3). 
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Figure 3. Schematic view of the paracentric inversion of chromosome 10q generating the 
transforming sequence RET/PTC1. 
 
 In RET/PTC1 rearrangement, the unscheduled expression of RET 
tyrosine kinase with its overespression, the deletion of negative regulatory 
domains of the receptor and constitutive oligomerization of PTC1 proteins are 
responsible for PTC1-transforming activity in the thyroid.  
The amino terminal region of H4 (paragraph 1.3) is responsible for the 
dimerization of the PTC1 oncoprotein in vivo. This region, containing a  
putative leucine zipper, mediated dimerization and is essential for tyrosine 
hyperphosphorylation and the transforming activity of PTC1 (Tong et al 1997) 
(Fig. 4). 
 
 
 
Figura 4 Mechanisms for RET/PTC1 activation. The wild-type RET protein, the PTPRJ 
tyrosine phosphatase, and the rearranged RET/PTC1 oncoproteins are depicted. 
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 Mutations in BRAF were the most recently identified MAPK effector in 
thyroid cancer. The proto-oncogene form of BRAF situated on 7q24 encodes a 
serine/threonine kinase that transduces regulatory signals through the Ras–Raf–
MEK–ERK cascade. Among point mutations of exon 15 in thyroid cancers, 
BRAFV600E is the most common alteration in sporadic papillary carcinoma.  
Gain of function mutations of BRAF are found in 29–69% of papillary thyroid 
carcinoma but not in follicular thyroid carcinoma, and in up to 13% of poorly 
differentiated thyroid carcinoma and 35% of undifferentiated thyroid 
carcinoma. BRAF mutations in papillary thyroid carcinoma correlate with 
distant metastasis and more advanced clinical stage, and occur at a significantly 
higher frequency in older patients. 
 The neurotrophic receptor-tyrosine kinase NTRK1 (also known as TRK 
and TRKA) was the second identified subject of chromosomal rearrangement 
in thyroid tumorigenesis. The NTRK1 proto-oncogene (which is located on 
chromosome 1q22) encodes the transmembrane tyrosine-kinase receptor for 
nerve growth factor. The activated receptor initiates several signal-transduction 
cascades, including ERK, PI3K and the phospholipase-Cgamma (PLCgamma) 
pathways. NTRK1 rearrangements, which show ectopic expression and 
constitutive activation of the tyrosine kinase that are analogous to RET 
rearrangements, have been noted in 5–13% of sporadic but only 3% of post-
Chernobyl childhood papillary thyroid carcinomas.  
 Unlike other solid neoplasms, Ras is the least prominent participant in 
thyroid carcinogenesis. Three Ras proto-oncogenes are implicated in human 
tumorigenesis: HRAS (which is located on chromosome 11p11), KRAS (which 
is located on chromosome 12p12), and NRAS (which is located on 
chromosome 1p13). Mutations involving codon 61 of HRAS and NRAS have 
been reported with variable frequency in thyroid neoplasms. Ras mutations are 
more common in iodine-deficient than iodine-sufficient areas and in lesions 
with follicular architecture (including follicular carcinoma and follicular 
variant papillary thyroid carcinoma) than in typical papillary thyroid 
carcinoma. Interestingly, activating Ras mutations are rare in radiation-induced 
thyroid cancers of Chernobyl. 
 
1.3 H4(D10S170) 
 The H4(D10S170) gene maps on the long arm of chromosome 10 at 
10q21 (Grieco et al. 1990). The H4(D10S170) gene, also called CCDC6 
(Coiled Coil Containig 6), contains 9 exons that encode for a transcript of 3 Kb 
and shows an open reading frame (ORF) of 585 aa. The H4 gene promoter, 
localized within 259 bp upstream of the ATG site, drives the gene expression 
ubiquitously in various human tissues including thyroid (Tong et al. 1995). 
Since the H4 gene is ubiquitously expressed, the specificity of the PTC-1 
activation is due to the specificity for thyroid tissue of the somatic 
rearrangement of the ret proto-oncogene. 
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 Sequence analysis of H4(D10S170) gene product shows extensive 
regions of alpha helices which have a high potential to adopt a coiled-coil 
conformation. Coiled-coils are formed by two or three alpha-helices that are 
strongly amphipathic and supercoil around each other, crossing at an angle of 
ca 20° (Lupas et al 1991). It has been shown that such regions can be involved 
in protein dimerization or oligomerization. The ‘sticky’ portion of 
H4(D10S170), that consists in 185 aa, from the aminoacid 53 to the 237, is 
only in part disrupted by the rearrangement and is responsible for RET/PTC1 
dimerization and, hence, for constitutive activation of its tyrosine-kinase 
activity. 
Moreover the N-terminal portion of H4 protein contains a poly-Gly region, 
while a poly-Pro region is present at the C-terminal. The C-terminal domain of 
H4 (amino acids 442-451) contains a putative SH3-binding sites domain, as 
defined by the PXXP motif (where X is any amino acid). SH3-binding domains 
play an important role in protein-protein interactions in numerous cellular 
processes, including clathrin-mediated endocytosis (McPherson 1999). For 
example, Grb2, amphiphysin, and PLCγ all bind to the SH3-binding domains 
of dynamin (Vidal et al 1998). The presence of a putative SH3-binding domain 
in H4(D10S170) gene product suggests that this protein might be a cytoskeletal 
one. 
Some of the features of the H4 gene product are summarized in Table 1 
 
 
 
Table 1 
 
 It is not clear why RET/PTC1 has been found activated only in thyroid 
papillary carcinomas, since in vitro irradiation is able to induce its activation 
also in fibroblasts (Ito et al. 1993). 
Recently, Nikiforova et al. (2000) suggested that the spatial contiguity of RET 
and H4 chromosomal loci might be responsible for the high frequency of 
RET/PTC1 radiation-induced rearrangements in thyroid human cells. 
 The H4/RET rearrangement is not the only one involving the 
H4(D10S170) gene, although it is the more frequent. A new chromosomal 
rearrangement involving the H4(D10S170) gene has been recently described 
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(Fig. 5). In two cases of atypical chronic myelogenous leukaemia (CML), the 
first 368 aa of H4(D10S170) fuse to the PDGFbetaR tyrosine kinase domain. 
The chromosomal event is a t(5;10) translocation. In the two cases of atypical 
CML in which the H4-PDGFbetaR transcript has been identified, the fusion 
gene codes for a 948 aa protein with most of the coiled-coil of H4(D10S170) 
and the transmembrane and the tyrosine kinase domains of the PDGFbetaR. 
The fusion protein oligomerization and constitutive activity is dependent on the 
coiled-coil domain of the H4(D10S170) gene. The reciprocal product of the 
translocation has not been found (Kulkarni et al. 2000; Schwaller et al. 2001). 
 
 
 
Figure 5 H4(D10S170) rearrangements. The red arrow shows the RET/PTC1 and the black 
one shows the H4/PDGFbetaR breakpoint.  
 
 In the various RET/PTC oncoproteins, little is known about the normal 
role of the 5' fusion partners. Some common features such as constitutive 
expression and the presence of dimerization domains have been observed for 
all the RET-fused genes identified so far. The ubiquitously expressed 
promoters of the 5'-fused sequences are responsible for the ectopic expression 
of RET in epithelial thyroid follicular cells, which do not normally express this 
protooncogene. 
Although this indicates that disruption of the normal regulation of the RET 
kinase is critical to the transforming properties, less is known about whether 
disruption of the normal function of the 5' partner gene might also have an 
important role. To address this point, the identification of the normal 
physiological function of the heterologous RET fusion partners is required. 
Therefore, we have characterized the product of the first and most frequently 
observed RET-fused gene, H4(D10S170). 
 H4 protein is a nuclear and cytosolic protein (Celetti et al 2004) and its 
intracellular localization depends on several stimuli. Sequence analysis 
programs predict a putative Nuclear Localization Signal (NLS) in H4 amino 
acid sequence. The putative NLS of H4, that include the residues from aa 420 
to 426, is a pattern starting with P and followed within 3 residues by a basic 
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segmant containing 3 K/R residues out of 4 (Merolla et al, manuscript in 
preparation) (Fig. 6). 
 
 
Figure 6 Putative NLS sequence in H4 protein. Schematic representation of putative NLS in 
H4 sequence (upper panel). The loss of putative NLS sequence (GFP H4ΔNLS) delocalizes H4 
gene product in the cytoplasm; nuclei were stained with Hoechst 33258; a merge image is also 
shown (lower panel). 
 
  
 The H4 gene product is phosphorylated upon serum stimulation. We 
demonstrated that H4(D10S170) phosphorylation is ERK1 dependent and that 
S244 is the major site for this ERK1-dependent phosphorylation. This aa 
residue is embedded in the sequence (PXS/TP) and is located downstream the 
H4(D10S170) breakpoint generating RET/PTC1 oncogenes. This residue is 
also conserved in the course of the phylogenesis.  
 While overexpression of the H4(D10S170) gene was able to induce 
apoptosis of thyroid follicular epithelial cells, no proapoptotic function was 
observed for the S244 point mutant, thus suggesting that the H4(D10S170) 
protein phosphorylation by ERK1 is required for H4(D10S170)-induced 
apoptosis to occur. This was also suggested by the negative dominance exerted 
by the S244 point mutant on the H4(D10S170) proapoptotic activity.  
 No apoptosis was also observed by the overexpression of the 
H4(D10S170) truncated form corresponding to the portion of the protein 
included in RET/PTC1, while a negative-dominant effect on apoptosis was 
exerted by overexpressing this fragment together with the full-length 
H4(D10S170) protein. Furthermore, conditional expression of the 
H4(D10S170)-dominant negative truncated mutant protected cells from stress-
induced apoptosis. The data showing a role in apoptosis induction exerted by 
H4(D10S170) and the ability of its truncated form to rescue the cells by stress-
induced apoptosis suggest an explanation for the reported loss of H4(D10S170) 
expression in thyroid papillary carcinomas (Sheils et al 2000, Fusco et al 
manuscript in preparation). In the tumour initiation RET/PTC1, which is able 
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to form heterodimers with H4wt, might be able to modulate H4(D10S170) 
proapoptotic function negatively (Celetti et al 2004).  
 
1.4 The ATM Gene Function in DNA Damage Response 
 DNA damage is a serious threat to cellular homeostasis because it 
compromises the stability and integrity of the cellular genome. Sequence 
alterations in DNA arise from normal genomic transactions, spontaneous 
chemical changes in DNA constituents, replication errors, and endogenous and 
exogenous agents that inflict damage on the DNA. The greatest challenge to 
genome stability comes from these last agents, which induce various types of 
DNA lesion. If not repaired, some of these lesions are extremely cytotoxic, 
whereas others are mutagenic with consequences ranging from malfunction of 
the cell to its malignant transformation. 
DNA damage initiates various repair mechanisms that recognize and repair 
specific DNA lesions; genetic defects in crucial parts of these mechanisms lead 
to a group of human genetic disorders that are collectively called ‘genomic 
instability syndromes’. These diseases are characterized by degeneration of 
specific tissues, sensitivity to particular DNA damaging agents, chromosomal 
instability and a marked predisposition to cancer. Of the many kinds of DNA 
lesion, double-strand breaks (DSBs) are particularly effective in triggering the 
DNA-damage response. 
 The extremely cytotoxic DSB is induced by ionizing radiation, 
radiomimetic chemicals and oxygen radicals formed in the course of normal 
metabolism, and can also follow replication fork stalling. DSBs are also part of 
normal genomic transactions, such as meiotic recombination and the 
maturation of the immune system genes via V(D)J recombination. Importantly, 
it has been recently shown that uncapped telomeres in senescent cells attract 
the same damage-response proteins that are recruited to DSBs and evoke an 
unregulated DNA-damage response. An ongoing DSB response has been also 
observed in precancerous cells and tumor tissues. 
Eukaryotic cells use two main mechanisms to repair DSBs: nonhomologous 
end-joining (NHEJ), an error-prone ligation mechanism that acts throughout 
the cell cycle; and a high-fidelity process based on homologous recombination 
between sister chromatids, which is functional in the late S and G2 phases of 
the cell cycle.  
The signaling network of DNA damage response affects numerous cellular 
systems. One of its hallmarks is the activation of cell-cycle checkpoints, which 
temporarily halt the cell cycle while the damage is assessed and repaired. 
Indeed, DSBs lead to profound changes in basic cellular processes such as gene 
expression, and protein synthesis, degradation and trafficking.  
 The most important process for the survival of a cell following ionizing 
radiation is the repair of DNA double strand breaks (DSBs) (Leskov KS   et al, 
2001). The product of the ATM gene which is mutated in the cancer prone 
disorder, Ataxia-teleangectasia (A-T), appears to be a major regulator of 
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cellular responses to ionizing radiation and plays an essential role in 
maintaining genome stability (Kastan, 2000; Shiloh, 2003).  
 ATM belongs to a conserved family of proteins termed the ‘PI3K-like 
protein kinases’ (PIKKs), most of which possess a serine/threonine kinase 
activity and all of which, as their name indicates, contain a domain with motifs 
that are typical of the lipid kinase phosphatidylinositol 3-kinase (PI3K). 
Four mammalian PIKKs are involved in the DNAdamage response: DNA-PK, 
which has a role in the NHEJ repair pathway; ATM; ATR; and hSMG-1. 
Whereas ATM and DNA-PK primarily respond to DSBs, ATR mainly 
transduces the signal emanating from UV damage and stalled replication forks, 
but it also responds to DSBs, albeit later and with slower kinetics. The hSMG-
1 kinase responds to both UV damage and DSBs. 
Whereas ATM and ATR share substrates in the DSB response, they show 
selective substrate specificities in response to different genotoxic stresses and 
DSB inducers (Fig. 7). 
 
Figure 7 Separate and overlapping roles of ATM and ATR in responses to genotoxic 
stress. The protein kinases ATM and ATR activate response networks after genotoxic stress by 
phosphorylating key proteins in various signaling pathways. The two protein kinases share 
substrates in the DSB response, but ATM functions upstream of ATR in some phases of the cell 
cycle during this response. 
 
 ATM exists as an inactive dimer until DNA double-stranded breaks 
induce its activation by intermolecular autophosphorylation of Ser1981 of 
human ATM, leading to the generation of active monomers (Bakkenist and 
Kastan, 2003). ATM activation is facilitated by the  interaction with the 
MRE11-RAD50-NBS1 complex that functions in DNA damage repair (Lee 
and Paull, 2004). Activated ATM triggers a series of downstream events, 
including phosphorylation of H2AX (γH2AX) and Brca1 to promote DNA 
damage repair and phosphorylation/stabilization of p53 leading to either cell 
cycle arrest (Shiloh 2003) or apoptosis. 
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2. AIMS OF THE STUDY 
The aim of this study is to understand the role of H4(D10S170) gene in the 
signal transduction pathways activated by DNA damage and other cellular 
stress as critical determinant of cell survival and cellular transformation.  
It has been reported a high frequency of H4 rearrangements in radiation-
induced thyroid tumours, and recent observations suggested us that H4 protein 
could be phosphorylated by the phosphatidylinositol-3-OH kinase-like kinase 
(PI(3)KK) ATM after exposure to ionizing irradiation.  
The purpose of the present investigation is then to verify:  
1. if H4 interacts and is phosphorylated by ATM;  
2. if phosphorylation at ATM-putative phosphorylation sites governs H4 
intracellular localization;  
3. H4 location and phosphorylation in A-T cells;  
4. whether phosphorylation of H4(D10S170) could be important during 
cell cycle perturbations after DNA damage;  
5. if the phosphorylation of H4(D10S170) is required for radio-resistant 
DNA synthesis;  
6. the role of H4 in modulation of radiation sensitivity;  
7. if the phosphorylation of ATM putative phosphorylation site/s is 
required for H4(D10S170) induced apoptosis in response to DNA 
damage;  
8. if the overexpression of H4 proteins mutated at the ATM 
phosphorylation sites act in a dominant negative manner to inhibit the 
normal function of endogenous H4;  
9. if the involvement of H4 in ATM-dependent DNA damage response is 
p53 dependent.  
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3. MATERIALS AND METHODS 
3.1 Materials, antibodies 
Etoposide [4′-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-
glucopyranoside), VP-16-213] is an antitumor agent that complexes with 
topoisomerase II and DNA to enhance double-strand and single-strand 
cleavage of DNA and reversibly inhibit religation. 
Bleomycin (Blenoxane, Bleo, Blexane) is an antineoplastic antibiotic isolated 
from Streptomyces verticillus. Binds to DNA, inhibits DNA synthesis and 
causes DNA scissions at specific base sequences. 
Hydroxyurea is an antineoplastic. Inactivates ribonucleoside reductase by 
forming a free radical nitroxide that binds a tyrosyl free radical in the active 
site of the enzyme. This blocks the synthesis of deoxynucleotides, which 
inhibits DNA synthesis and induces synchronization or cell death in S-phase. 
Etoposide, Bleomycin and Hydroxyurea were obtained from Sigma Chemical, 
Co.  
Anti-myc and secondary antibodies were from Santa Cruz Biotechnology.  
 
3.2 Plasmids, GST Fusion Protein Production, Expression 
vectors.  
pCDNA4TO-H4(D10S170) mutants (-T143A, -T191A, -T205A, -T323A, -
T325, and -T434A) were obtained using the Quick Change Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA). H4(D10S170) cDNA fragments 
corresponding to nt 1231-1428 and to nt 450-1200 were amplified by PCR and 
then subcloned, respectively, in the BamHI-EcoRI and in the BamH1-SmaI 
restriction sites of pGEX2TK (Pharmacia). The resulting GST fusion proteins 
(GSTH4PR and GSTH4BS) were produced in BL21 bacteria and  purified by 
glutathione-agarose beads. 
pCDNA-Flag ATMwt and pCDNA-Flag-ATMKD have been generously 
provided by M.Kastan, and have been previously described. 
 
3.3 Cell culture and transfection 
TPC-1, 293T and SAOS2 cells were mantained in Dulbecco’s modified 
Eagle’s medium supplemented with 10% foetal bovine serum; Hela and ataxia 
telangiectasia cells (B-Lymphocyte, GM01526; GM02184; Coriell Cell 
Repositories, Camden, NJ) were mantained in RPMI, supplemented with 15% 
foetal bovine serum. The Fugene reagent (Roche) was used to transfect cells 
accordingly to the manufacturer’s  instructions.  
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3.4 Antibody production  
The anti-H4(C-17-V) antibodies were generated by immunization of rabbits 
with OVA-conjugated peptides (CYKALQEENRDLRKASV), aminoacids 84-
99). The antibodies were affinity purified by using of the KLH-conjugated 
peptide. 
 
3.5 Western Blotting  
Western Blotting was performed as described (Laemli, UK, 1970; Towbin H, 
Staehelin, and Gordon J, 1979).  
Blots were hybridized with antibodies to the indicated proteins and then with 
their corresponding species-specific horseradish peroxidase-conjugated 
secondary IgG and visualised using the ECL chemi-luminescence system 
(Amersham/Pharmacia)  
 
3.6 In Vitro Kinase Assays 
Cell extracts were prepared from 293T cells which had been transfected with 
FLAG-ATM. Cleared supernatants were immunoprecipitated with anti-Flag 
M2 antibody (Sigma Chemical, Co). In vitro kinase assay for ATM were 
performed as described earlier (Canman , Science, 1998). Immunoprecipitated 
Flag-ATM was confirmed by WB with anti-Flag antibody. Radiolabeled 
proteins were visualized  and quantitated on PhosphorImager  (Molecular 
Dynamics). For endogenous ATM kinase reactions, endogenous ATM was 
immunoprecipitated with ATM monoclonal antibody (NB104, Novus 
Biological, Inc), and in vitro kinase reactions were carried out. 
 
3.7 Precipitation of 3H thymidine labeled DNA with 
trichloroacetic acid 
Cells were plated at 1 x 105/4 cm glass dish. One hour prior to harvesting cells  
were labelled with 1 mCi ml-1 3H thymidine. Cells were lysed in 25 mM Tris-
HCl pH 8.0, 25mM EDTA, 0,5% SDS. 60% TCA was then added to a final  
concentration of 12%. Precipitated nucleic acids were collected and the amount 
of radioactivity was counted after the addition of Ecolume scintillant. Each 
experiment was carried out in triplicate. 
 
3.8 Flow cytometry 
Cells were harvested when subconfluent, fixed in 80% ethanol for 1 h at -20°C, 
rehydrated in PBS, and then treated with RNase A (100U/ml) for 30 min. 
Propidium iodide (50 µg/ml) was added to the cells for 30 minutes in the dark. 
Samples were analysed with a CYAN flow cytometer (Dako Corporation, San 
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Jose, CA, USA) using an argon-ion laser tuned to 488nm measuring forward 
and orthogonal light scatter, and red fluorescence measuring area and either 
peak of the fluorescent signal. Data were aquired using SUMMMIT® software 
and analysed with Modfit® software. 
 
3.9 Mitotic cell population assessment   
Cells were either untreated or irradiated with 10 Gy as indicated, then 
incubated for 1 hour at 37°C before fixation. Cells in mitosis were determined 
by staining with propidium iodide and antibody to phospho-histone H3 (P-H3) 
(Cell Signaling, Beverly, MA), followed by fluorescein isothyocyanate (FITC)-
conjugated secondary antibody (Jackson Immunoresearch Laboratories, West 
Grove, PA) and the percentage of the M-phase cells was determined by flow 
cytometry. 
 
3.10 Clonogenic assays 
Cell lines were plated in triplicate at limiting dilutions into 6-well  plates, 
incubated for 24 h, and then exposed to a range doses of ionizing irradiation (0-
6Gy) followed by incubation for ten days. Prior to counting colonies, cells 
were fixed in 95% methanol and stained with crystal violet. A population of  
more than 50 cells was counted as one survived colony. The mean colony 
counts +/- standard errors are reported. 
 
3.11 Indirect Immunofluorescence  
The indirect immunofluorescence was performed as follow. 
For immunofluorescence staining the H4(D10S170) gene product was detected 
with rabbit polyclonal antibody anti-H4 at 1:50 dilution applied 1h at 37 °C in 
a humidified chamber and a fluorescein isothiocyanate (FITC)-conjugated 
donkey anti-rabbit secondary IgG antibody at 1:50 dilution (Jackson 
ImmunoResearch Laboratories Inc., West Grove, OK, USA).  
For immunofluorescence staining, exogenous myc-H4wt and myc-H4T434A 
were detected with mouse monoclonal antibody anti-myc (Santa Cruz) at 1:50 
dilution applied 1h at 37 °C in a humidified chamber and a fluorescein 
isothiocyanate (FITC)-conjugated donkey anti-mouse secondary IgG antibody 
at 1:50 dilution (Jackson ImmunoResearch Laboratories Inc., West Grove, OK, 
USA).  
After washing three times with PBS, the slides were washed with Hoechst 
33258 (final concentration, 1 µg/mL; Sigma-Aldrich) to stain nuclei and then 
mounted in aqueous medium (Sigma, Milan, Italy). 
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The fluorescent signal was visualized with an epifluorescent microscope 
(Axioskop 2, Zeiss) interface with the image analyzer software Axiovision 
(Zeiss, Gottingen, Germany). FITC was irradiated at 488 nm and detected via a 
505–560 nm band pass filter.  
 
3.12 Bromodeoxyuridine incorporation 
Cells were seeded on glass coverslips and bromodeoxyuridine (BrdUrd) was 
added to the cell culture medium at a final concentration of 100 µg/mL 
(BrdUrd Labeling and Detection kit, Boehringer Mannheim, Mannheim, 
Germany). After 1-hour incubation, cells were fixed with 70% ethanol/50 
mmol/L glycine (pH 2.0). Coverslips were incubated with anti-BrdUrd mouse 
mAb and with a FITC-conjugated anti-mouse antibody. All coverslips were 
counterstained in PBS containing Hoechst 33258 (final concentration, 1 
µg/mL; Sigma-Aldrich), rinsed in water and mounted in Moviol on glass 
slides. The fluorescent signal was visualized with an epifluorescent microscope 
(Axioskop 2, Zeiss) interfaced with the image analyzer software Axiovision 
(Zeiss, Gottingen, Germany). 
3.13 RNA silencing 
Small inhibitor duplex RNAs targeting human H4(D10S170) were designed 
with a small interfering RNA (siRNA) selection program available online at 
http://jura.wi.mit.edu/siRNAext/ and were chemically synthesized by 
PROLIGO (Boulder, CO). Sense strand for siRNA-345 targeting was (H4i-
345) 5’-CAGGGCUGAGCAGGAAGAAGA AU-3’, and sense strand for 
siRNA-419 targeting was (H4i-419) 5’-AAACCCUUGCUGUAAAUUAUG 
AG-3’. As a control, a not specific siRNA duplex containing the same 
nucleotides but in irregular sequence (scrambled) was used. The day before 
transfection, 1 X105 cells were plated in 60-mm dishes in medium 
supplemented with 10% fetal bovine serum and without antibiotics. 
Transfection was done using 100 nmol siRNA and  Oligofectamine reagent 
(Invitrogen, Groningen, the Netherlands) following the manufacturer’s 
instruction. 48 hours after transfection cells were exposed to genotoxic stress 
(etoposide, hydroxyurea, different doses of ionizing radiation) and BrdUdr 
incorporation. 
 
3.14 MTT colorimetric assays   
To determine cell viability, an MTT assay was performed as directed by the 
manufacturer (Roche). Briefly, the medium was removed from the cells and 
replaced with a fresh medium containing 0.5 mg/ml 3-(4,5-dimethylthiazol-
2yl)-2-5-diphenyltetrazolium bromide (MTT) (Roche, 1 465 007) and 
incubated for 3 h at 37°C. The medium was removed and the coloured 
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precipitate formed by cleavage of MTT in living cells was solubilized with 
isopropyl alcohol containing 0.05 M HCl. Cell survival was determined by 
absorbance at 570 nm. The background was determined by absorbance at 690 
nm. 
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4. RESULTS 
 
4.1 DNA damage induces ATM-mediated phosphorylation of 
H4(D10S170) protein in vitro 
 Several putative phosphorylation sites for ATM are present in 
H4(D10S170) as predicted by ProfileScan primary sequence analysis and also 
conserved in philogenesis (Fig. 8). 
 
Figure 8 Alignment of H4 human protein sequence with Mus musculus, Xenopus laevis 
and Drosophila Melanogaster. Aminoacid alignment of human, mouse, Xenopus and 
Drosophila H4(D10S170) proteins (Gen BankTM accession numbers: Homo Sapiens 
AAC60637; Mus Musculus XP_988138; Xenopus Laevis  AAH45133; Drosophila 
Melanogaster NP_730234) were compared via a BLAST program (NCBI) as shown. Potential 
ATM family member consensus sequences (Kim, 1999) are highlighted in dark grey and 
predicted ATM phosphorylation sites are represented by the vertical hatched lines. 
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 H4(D10S170) protein was present in immunoprecipitates from 
unirradiated cells transfected with ATM (Fig. 9).  
 
 
 
Figure 9 H4 co-immuno precipitates with ATM. Extracts from 293T cells, transiently 
transfected with vector alone or expression vectors encoding Flag-ATM and myc-
H4(D10S170)wt , were immunoprecipitated with the anti-Flag and blotted with anti-myc 
 
 The requisite target sequence for phosphorylation by Atm (a serine or 
theonine followed by glutamine residue) (Kim et al, 1999; O’Neill et al 2000), 
was present in H4(D10S170) as Threonine at position 434 followed by a 
glutamine, Q. The GST-H4-PR (Proline-Rich region, nt 1231-1428) containing 
Threonine  434 (TQ) was good in vitro substrates for the wild type Atm kinase 
(Fig 1C). The caffeine pre-treatment impaired the H4-PR phosphorylation by 
wild-type ATM. A kinase-dead Atm was not able to phosphorylate H4 proline-
rich, too (not shown). 
Larger GST-H4 Bam-Sma fragment containing about 300 aminoacids 
surroundings threonine 191, threonine 205, serine 323 and serine 325 were 
then evaluated in these kinase assays. GST-H4 Bam-Sma was minimally 
phosphorylated by ATM. A GST-p53 peptide served as positive control and 
was efficiently phosphorylated by wild-type ATM (Fig. 10). 
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Figure 10 Thirty minutes after irradiation (4 Gy) immunoprecipitated Flag-tagged WT-ATM 
was incubated in presence or absence of 1 mM caffeine with recombinant proteins consisting 
of several deletion mutants of human H4(D10S170) fused to GST. A p53-GST protein was used 
as positive control. 
 
4.2 ATM regulates H4(D10S170) through an increased half-life 
 To investigate the H4(D10S170) involvement in the DNA damage 
signalling pathway we assessed whether H4(D10S170) expression was induced 
by different genotoxic stresses. Cells treated with ionizing irradiation or 
etoposide or bleomycin (Fig. 11 and 12) showed increased levels of 
H4(D10S170) protein suggesting that the induction of H4(D10S170) protein 
may be a general response to DNA damage.  
 
 
 
 
 
Figure 11 DNA damage increases H4(D10S170) half-life. Lysates from HeLa cells exposed 
to 4Gy of IR for 90’ or treated with bleomycin (BLEO, 5µg/ml for 6 h) or untreated (NT) were 
immunoblotted with anti-H4C17-V-ab. Anti α-tubulin was used for normalization. 
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In myc-H4(D10S170) wild-type each of the six putative phosphorylation sites 
was altered (from serine/threonine to alanine) and the phosphorylation status 
and stabilization of the mutant derivatives assessed in cells treated with 
etoposide. The protein level of H4T434A  was not increased  in cells treated 
with etoposide but retained the constitutive level of expression observed with 
wild type H4(D10S170) in untreated cells (Fig. 12); similar effects were not 
observed with any other H4 mutants (data not shown).  
 
 
 
Figure 12 HeLa cells transfected with 5 µg of expression vectors encoding H4(D10S170)wt, 
H4T434A or empty vector were treated with etoposide  (10µM for 6h) and immunoblotted with 
anti-myc monoclonal antibody recognizing exogenous H4(D10S170). 
  
One possible explanation for our results on the regulation of H4(D10S170) by 
ATM is that ATM controls the abundance of H4 through an extended half-life. 
Although the half-life of  H4 wt and H4T434A was similar in the absence of 
etoposide, the mutant was significantly less stable in presence of etoposide (Fig 
13). 
 
 
 
 
 
30 
 
Figura 13 HeLa cells were transfected as in fig. 10 and treated with or without etoposide 
(10µM) for 6h, as indicated. Cycloheximide (10mg/ml) was added and extracts were then 
immunoblotted with an anti-myc antibody at the indicated times. The level of PCNA is shown 
below each treatment as a loading control. 
 
 As shown in figure 14, when cells were not treated with a DNA-
damaging agents, the proteasome inhibitor MG132 led to significantly higher 
H4(D10S170) protein levels. Moreover, in the presence of MG132, levels of 
H4(D10S170) were not further increased upon IR or etoposide treatment (data 
not shown). 
 Thus, Threonine 434 is a functionally important residue in regulating 
H4(D10S170) stability in response to DNA damaging agents, etoposide, 
bleomycin and ionizing radiation.  
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Figure 14 Lysates from HeLa cells treated with etoposide (10µM for 6h), with MG132 (40µM 
at the indicated times) or untreated (NT) were immunoblotted with the anti-H4C17-V Ab. 
 
4.3 Phosphorylation of H4(D10S170) at Thr 434 governs 
intracellular localization 
 We investigated the mechanism through which the phosphorylation of 
Thr 434 may influence H4(D10S170) activity, and to this end we considered a 
role in regulating intracellular localization. In normal cells H4(D10S170) had a 
nuclear and cytosolic localization: we observed an increase in nuclear staining 
intensity occurring after etoposide treatment (Fig. 15c) correlating with the 
increased level of H4(D10S170) protein previously shown (Fig. 12). A similar 
effect was observed with exogenous H4, again exhibiting enhanced nuclear 
staining in cells treated with etoposide (Fig. 15g). Notably, the H4T434A  was 
excluded from nuclei, being localized to the cytosol and treatment of cells with 
etoposide failed to alter its localization (Fig. 15i, k). 
 Therefore Thr 434 is able to regulate the intracellular localization of H4 
in response to DNA damaging stresses. 
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Figure 15 Intracellular localization of H4(D10S170)wt and H4T434A in HeLa cells after 
Etoposide treatment. HeLa cells were immunostained with the anti-H4C17V antibody 
recognizing endogenous H4(D10S170) pre (a and b) or post (c and d) treatment with etoposide 
(10 M for 12h). HeLa cells were transfected with expression vectors encoding wild type 
H4(D10S170) (e-h) or H4T434A (i-l)  fused to myc epitope and immunostained with anti-myc 
monoclonal antibody pre (e, f, i, j) or post (g, h, k, l) etoposide treatment (10µM for 12 h). 
Hoechst staining shown in b, d, f, h, j and l. 
 
4.4 H4 location and phosphorylation in A-T cells 
Given the suggested  role for ATM kinase in the phosphorylation and 
regulation of H4(D10S170) protein, we were interested in evaluating 
H4(D10S170) expression in ataxia teleangectasia cells. In ataxia teleangectasia 
lymphoblast cell lines [GM 01526 (A-T); GM 02184 (WT)] endogenous H4 
localized to the cytoplasm and was excluded from the nucleus; etoposide 
treatment had no effect on this distribution (Fig. 16).  
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Figure 16 Intracellular localization of H4(D10S170)wt in ataxia-teleangectasia cells. 
GM02184 (WT) and GM01526 (A-T) lymphoblast  cells were immunostained for endogenous 
H4(D10S170) with anti-H4C17V Ab pre (a, b, e, f) or post (c, d, g, h) treatment with etoposide 
(10 M for 12 h). Hoechst staining is shown in b, d, f and h. 
 
No phosphorylation of the GST-H4-PR fusion protein was detected in A-T 
lymphoblasts up to 6 h after exposure to 10 Gy of IR, as shown in vitro kinase 
assay (Fig. 17) suggesting that the mechanism of threonine 434 
phosphorylation following ionizing irradiation is defective in A-T 
lymphoblasts cells. In irradiated GM02184 normal lymphoblasts cells GST-
H4-PR fusion protein was efficiently phosphorylated. Phosphorylation by 
ATM was specific since a caffeine (1mM) pre-treatment completely impaired 
this phosphorylation. Since in GM01526 ataxia teleangectasia cells ATM is 
missing these results further strengthen the hypothesis that ATM kinase 
phosphorylates Threonine 434 to regulate the intracellular location and activity 
of H4(D10S170). 
 
 
Figure 17 In vitro phosphorylation of H4(D10S170) in ataxia teleangectasia cells. In ataxia 
teleangectasia lymphoblasts [GM02184 (WT) and GM01526 (A-T)] thirty minutes after 
irradiation (4Gy) immunoprecipitated endogenous ATM were incubated with GST-H4-PR 
(proline rich), in presence or not of caffeine (1mM). 
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4.5 Expression of H4(D10S170) mutants  increased cells 
survival following exposure to ionizing irradiation 
 In order to investigate whether H4(D10S170) can modulate the cell 
response to DNA damage the transient inhibition of DNA synthesis after 1 
hour exposure to 10 Gy of ionizing irradiation in cells expressing wild-type or 
mutant H4(D10S170) was assessed. 293T cells transiently transfected with 
vectors expressing H4 wild-type or H4 mutants, like the H4(D10S170)-
encoding portion of RET/PTC1 oncogene, H4(1-101), or H4(D10S170) with 
the threonine 434 mutated in alanine, H4T434A, were exposed to gamma 
radiation and analysed for 3H-thymidine incorporation: H4(1-101) and 
H4T434A expressing cells  progressed to S-phase and had therefore 
incorporated radio-labeled thymidine. In contrast cells transfected with wild-
type H4 incorporated less thymidine than control vector (Fig. 18). To 
investigate the potential role of these H4 mutants, we evaluated the survival of 
HeLa cells that transiently expressed the wild type or mutant H4(D10S170) 
proteins after two weeks from irradiation. The cells expressing either H4 
mutant truncated at aminoacid 101 (H4 1-101) or H4(D10S170) mutated at Thr 
434 (H4T434A), alone or together with H4wt, appeared radioresistant 
compared with cells transfected with control vector or H4(D10S170)wt (Fig. 
19). Thus, similar to the truncated mutant H4(1-101) (Celetti, et al, 2004), the 
single point mutant H4T434A, heterodimerizing with H4wt, was able to 
coimmunoprecipitate efficiently the wt H4(D10S170) protein (Fig 20), 
behaving as dominant negative on H4wt protein function and conferring 
growth ability to the cell in long term colony assay. 
 
 
 
Figure 18 Expression of H4 mutants increased 3H Thymidine incorporation  following IR 
exposure 293T cells transiently transfected with empty vector or H4(D10S170)wt, H4(1-101), 
H4T434A were assessed for inhibition of DNA synthesis 30 min after exposure to 10 Gy of 
ionizing irradiation. The average of at least triplicate samples, is reported. The graphic shows 
the ratio between 3H thymidine incorporation in irradiated over not irradiated cells (control). 
Error bars indicate s.e.m. 
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Figure 19 Expression of H4 mutants increased cell survival following IR exposure. 
Expression of H4(D10S170) mutants increased radioresistance. HeLa cells expressing empty 
vectors, wild type, deletion or phosphorylation-site mutants constructs of H4(D10S170) were 
exposed to 0-6 Gy of ionizing irradiation and incubated for two weeks prior to fixation, 
staining and assessement of colony formation. The clonogenic survival assays were performed 
in triplicate. Error bars indicate s.e.m. 
 
 
 
 
Figure 20 H4T434A heterodimerizes with H4wt protein. 293T cells were transfected with the 
GFP empty vector (mock), GFP-H4wt, GFP-H4wt together with myc-H4T434A: the cell lysate 
were immunoprecipitated with anti-myc and blotted with anti GFP. Westerns blot stained with 
anti-myc or anti-tubulin were performed as controls. 
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4.6 Phosphorylation of Thr 434 is required for apoptosis in 
response to DNA damage 
 To assess the functional significance of the interaction betweeen 
H4(D10S170) and ATM kinase we examined the involvement of ATM in H4-
induced apoptosis. Transient expression of H4(D10S170) gene product was 
associated with induction of apoptosis in thyroid cells. TPC-1 cells, that 
harbours the RET/PTC1 rearrangement and have lost the expression of the 
normal unrearranged H4(D10S170) allele (Jossart et al 1996), transiently 
transfected with H4(D10S170)wt showed impaired apoptosis if pretreated with 
50 nM wortmannin and 1 mM caffeine, known inhibitors of ATM kinase 
activity (Fig. 21). In addition, in TPC-1 cells, H4T434A expression had a 
dominant negative effect on H4wt-mediated apoptosis (Fig 21).  
 
 
 
 
Figure 21 Percentage of survival evaluated by MTT analysis on TPC-1 cells expressing 
GFP, GFPH4wt, GFP H4T434A, GFPH4wt together with mycH4T434A treated or not treated 
with 50 nm wortmannin or 1 mM caffeine. Values represent the mean of sextuplicate 
measurements and the plotted values represent the mean +/- s.e.m. of three independent 
experiments. 
 
 
 Moreover, flow cytometry analysis showed that introduction of 
H4(D10S170)wt into etoposide-treated TPC-1 cells  slightly increased the level 
of sub-G1 cells whereas introduction of the dominant negative H4T434A 
mutant reduced the level of apoptotic cells (Fig. 22). These results indicate a 
role for ATM kinase in contributing to H4-mediated apoptosis. 
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Figure 22 FACS analysis of TPC-1 cells expressing myc-H4wt, myc-H4T434A, and 
pcDNA vector alone, before and after the addition of Etoposide (10µM) for 12 hours. The 
percentage of cell death was determined after 30 hours from transfection as subG1 population. 
The plotted values (lower panel) represent the mean +/- s.e.m. of three independent flow 
cytometry analysis. 
 
 To rule out whether H4-apoptotic activity was p53 dependent, we used 
SAOS cells lacking the p53 gene product. In order to assess the function of  
Threonine 434 in regulating the DNA damage response, we compared the 
ability of wild type H4(D10S170) and H4T434A to enhance p53-dependent 
apoptosis in response to DNA damage. In SAOS2 cells, in which we 
previously observed H4-mediated cell death (Celetti et al 2004), the 
introduction of exogenous H4(D10S170) followed by treatment with etoposide 
caused cell cycle delay, increasing the G1/S population and the level of cells 
undergoing apoptosis (subG1) (Table 2). The presence of wild type p53 do not 
substantially modify the level of apoptotic cells. H4T434A failed to increase 
apoptosis either in presence of stress agents, either with p53, conferring a 
growth advantage to the cells (Table 2). These results support the idea the Thr 
434 phosphorylation by ATM kinase is a functionally important event in the 
DNA damage response, and that it is independent by p53.   
 
Table 2 In SAOS2 cells the introduction of exogenous H4(D10S170) followed by 
treatment with etoposide caused cell cycle delay. Cell cycle distribution (%) of SAOS-2 cells 
transfected with the indicated constructs (Ctrl: mock transfection with pcDNA vector alone; 
Eto: Etoposide (20 M). Cells were transfected with 3  g of  p53, pcDNA-H4wt, and -
H4T434A). 
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4.7 Silencing of H4(D10S170) gene product increase cell 
survival, DNA synthesis and mitotic cell population after 
exposure to genotoxic stress 
 
 To determine H4(D10S170) role, we used small interfering RNAs 
(siRNAs) in the form of two independent, non-overlapping, 21-base pair RNA 
duplexes that target H4(D10S170) to inhibit its expression (Fig. 23).  
 
 
 
Figure 23 H4(D10S170) gene expression inhibition. Lysates of 293T cells, transfected with 
siRNA oligos targeting H4(D10S170) or control oligos for 48 hours, were immunoblotted with 
anti-C17V-H4 and α-tubulin antibodies 
 
 
 
 In the first instance we evaluated  the percentage of survival on HeLa 
cells transfected with siRNA oligos and treated or not with several DNA 
damaging agents: the H4i-345 and H4i-419 oligos were able to confer growth 
advantage to the cells in comparison to the scrambled oligo (Fig 24).  
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Figure 24 H4(D10S170) inhibition results in cell survival. Percentage of survival evaluated 
by MTT analysis on HeLa cells transfected with siRNA oligos (H4i-345, H4i-419 and 
scrambled) and treated with 20 µM etoposide or 10 Gy of IR for 12h, as indicated. 
 
  
Replicative DNA synthesis was assessed in HeLa cells, 1 hour after 10 Gy 
doses of ionizing radiation were given: unlike the control cells, H4(D10S170)-
inhibited cells showed increased BrdUrd incorporation (Fig. 25).  
 
 
Figure 25 H4(D10S170) inhibition results in increased DNA synthesis following IR 
exposure. For DNA synthesis BrdUrd incorporation was assessed 1 h after 10 Gy of IR in 
293T cells transfected with siRNA oligos; the DNA synthesis in unirradiated cultures was set to 
100% for cells transfected with scrambled oligos or siRNA oligos targeting H4(D10S170). 
 
 
 
40 
 
 Then, we irradiated H4(D10S170)-inhibited and control cells with 10 
Gy of IR to assess the mitotic population. About double amount of 
H4(D10S170)-inhibited cells, with respect to the control cells, treated with 10 
Gy entered into mitosis (Fig 26). 
 
 
 
Figure 26 H4(D10S170) inhibition results in increased progression into mitosis after IR. 
The mitotic percentage change of 293T cells transfected with siRNA oligos (H4i-345, H4i-419 
and scrambled) 90 min after 10 Gy ionizing irradiation is shown. Mitotic cell percentage was 
determined by anti-phosphohistone-H3 hybridization followed by propidium iodide staining in 
bi-parametric flow cytometry analysis.  
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5. DISCUSSION AND CONCLUSIONS 
 Signal transduction pathways activated by DNA damage and other 
cellular stresses are critical determinants of cell survival and cellular 
transformation. The predisposition of thyroid cells to chromosomal 
recombination has been ascribed to their relative resistance to cell death 
following DNA damage and to higher DNA end-joining enzimatic activity 
(Smith, 2003; Little, 2003). In the present study, we hypothesized that 
H4(D10S170) gene product might be involved in ATM-dependent DNA 
damage response on account of a high frequency of H4 rearrangements in 
radiation-induced thyroid tumours.  
 We intended to explore if H4(D10S170) interacted and was 
phosphorylated specifically by the ATM kinase, if H4(D10S170) was directly 
involved in the DNA-damage response pathway and if the H4 involvement in 
the radiosensitivity cell mechanisms contributed to the thyroid carcinogenesis 
after chromosome breackage.  
 Several observations suggest that H4 is regulated by ataxia 
teleangectasia mutated (ATM) after DNA damage. First, ATM deficient cells 
show no H4 phosphorylation, and no nuclear protein in response to γ-radiation 
compared with cells expressing WT-ATM. Second, caffeine and wortmannin 
treatments strongly inhibits γ-radiation-induced phosphorylation and H4-
induced apoptosis. Third, the silencing of H4(D10S170) gene promotes 
radioresistant DNA synthesis and induces growth advantage to the cells, even 
in presence of genotoxic stresses. In this respect the dominant negative H4 1-
101, the portion of H4 rearranged with RET in RET/PTC1 oncogene, can elicit 
proliferative effects and stimulate cell cycle progression in presence of ionizing 
radiation.  
 The fact that phosphorylation of H4(D10S170) is induced by DNA 
damage defines H4(D10S170) as a feasible effector protein in the cellular 
response to DNA damage. In fact, we identified the threonine 434 at COOH-
terminus of H4(D10S170) as the ATM phosphorylation target site; moreover, 
we were able to ascribe the radioresistance DNA synthesis and the growth 
advantage that we observe with the truncated mutant 1-101 in presence of 
genotoxic stress to the lack of the threonine 434. 
Strickingly, the silencing of H4 gene reproduced the same effects. These 
results enforced the dominant negative role exerted by H4 mutants. 
No foci number differences were observed between scrambled and siRNA H4-
transfected cells upon radiation exposure.  Nevertheless, no H4 expression at 
sites of DNA damage have been reported neither colocalization with anti-
phospho H2AX has been detected (data not shown). Taken together these 
results suggest that H4(D10S170) is an ATM substrate involved in the DNA 
damage-signalling pathway in mammalian cells but its role in hierarchical 
branched pathway for the recruitment of repair and signaling proteins to sites 
of DNA damage is unknown and is at moment under investigation. Several 
targets of ATM kinase that are involved in cellular response to ionizing 
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radiation have been characterized previously, including p53, Chk2, Mdm2, 
Nbs1, Brca1, p53BP1 and Smc1 (Kastan and Lim 2000). In this report we add 
the H4(D10S170) gene product to the list of bona fide ATM targets. 
Phosphorylation of threonine 434 site appears to be involved in both the IR-
induced S phase checkpoint and in modulating radiation sensitivity. However, 
the mechanisms by which H4(D10S170) phosphorylation influences these 
processes remain to be worked out. The functional ramification of 
H4(D10S170) phosphorylation on DNA replication and on DNA 
recombination needs to be explored, as well. H4(D10S170) seems to have a 
somewhat general role in cellular stress responses because the data link it to 
response to diverse agents ranging from ionizing radiation to alkylating drugs 
and to oxidative stress as previously reported (Celetti et al 2004). In response 
to the agents other than ionizing radiation, H4(D10S170) could also be 
involved in stress pathway not involving ATM, and then establish a new link 
between DNA damage-induced signalling pathways and other protein 
complexes. This observation needs further investigation. 
 In conclusion, the results described here establish H4(D10S170) as a 
physiological target for ATM kinase in response to DNA damage signalling 
induced by etoposide treatment or ionizing radiation exposure and argue that 
ATM-mediated phosphorylation is involved in apoptosis mediated by 
H4(D10S170).  
Therefore, the first 101 aminoacids of H4 in RET/PTC1 and the loss of 
H4(D10S170) function might have a synergistic effect in the transformation 
process of the thyroid cells driven by the RET kinase.  
 Moreover demonstrating its involvement in cellular responses to DNA 
damage, this study introduces the H4(D10S170) gene product in one of the 
most important fields in cancer biology. First, damage to cellular DNA causes 
cancer (we know this from epidemiological studies, from animal models and 
from the observation that many human-cancer-susceptibility syndromes arise 
from mutations in genes involved in DNA-damage responses). Second, DNA 
damage is used to cure cancer (most therapeutic modalities that we currently 
use to treat malignancies target the DNA, including radiation therapy and many 
chemo-therapeutic agents). Third, DNA damage is responsible for most of the 
side effects of therapy. 
Considering the high frequency of gene rearrangements involving 
H4(D10S170) in neoplasia, the identification of the involvement of this gene in 
DNA damage and the future identification of the pathway involved will be 
useful for the establishment of new therapeutic approaches. 
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